Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MARINOL®
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target.
Mast cells: an expanding pathophysiological role from allergy to other disorders.
Very early MS -- insights from MRI.
A practical guide to the treatment of neuromyelitis optica.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
Clinical assessment of noninvasive intracranial pressure absolute value measurement method.
Pregnancy and Multiple Sclerosis (MS): A Beneficial Association. Possible therapeutic application of embryo-specific Pre-implantation Factor (PIF*).
The use of aminopyridines in neurological disorders.
Efficacy and safety of Alemtuzumab in treatment-naive patients with relapsing-remitting multiple sclerosis: Four-year follow-up of the Care-MS I study.
A new cognitive rehabilitation programme for patients with multiple sclerosis: the 'MS-line! Project'
Autonomic dysfunction: A unifying multiple sclerosis theory, linking chronic cerebrospinal venous insufficiency, vitamin D(3), and Epstein-Barr virus.
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis.
Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain.
HyperCKemia Related to the Initial and Recurrent Attacks of Neuromyelitis Optica.
Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination.
European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
The genetics of multiple sclerosis.
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
France Banned AB Science Drug Studies Because of Side Effects
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
Pages
« first
‹ previous
…
188
189
190
191
192
193
194
195
196
…
next ›
last »